Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,384.91
    -1,220.59 (-2.37%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Company News for Mar 25, 2024

  • Shares of FedEx Corporation (FDX) jumped 7.4% after the company reported third-quarter fiscal 2024 earnings of $3.86 per share, beating the Zacks Consensus Estimate of $3.49 per share.

  • AAR Corp.’s (AIR) shares tumbled 5.9% after the company reported third-quarter fiscal 2024 revenues of $567.3 million, missing the Zacks Consensus Estimate of $568 million.

  • Shares of Worthington Steel, Inc. (WS) soared 10.7% after the company reported third-quarter fiscal 2024 earnings of $0.99 per share, surpassing the Zacks Consensus Estimate of $0.80 per share.

  • CARGO Therapeutics, Inc.’s (CRGX) shares gained 3% after the company reported fourth-quarter 2023 loss of $1.49 per share, narrower than the Zacks Consensus Estimate of a loss of $1.62 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AAR Corp. (AIR) : Free Stock Analysis Report

FedEx Corporation (FDX) : Free Stock Analysis Report

CARGO Therapeutics, Inc. (CRGX) : Free Stock Analysis Report

Worthington Steel, Inc. (WS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research